73312-15-9 Usage
Description
4-CYANO-4-(3-METHYLPHENYL)CYCLOHEXANONE is a chemical compound with the molecular formula C15H17NO. It is a cyclic ketone that contains a cyano group and a methylphenyl group attached to a cyclohexanone ring. 4-CYANO-4-(3-METHYLPHENYL)CYCLOHEXANONE is known for its versatile chemical properties, making it a valuable building block in organic synthesis and a key intermediate in the production of pharmaceuticals and agrochemicals.
Uses
Used in Pharmaceutical Industry:
4-CYANO-4-(3-METHYLPHENYL)CYCLOHEXANONE is used as a building block for the synthesis of various pharmaceuticals. Its unique structure allows for the development of novel compounds with potential therapeutic applications, contributing to the advancement of medicine and healthcare.
Used in Agrochemical Industry:
In the agrochemical sector, 4-CYANO-4-(3-METHYLPHENYL)CYCLOHEXANONE serves as an intermediate in the production of agrochemicals. Its incorporation into these products can lead to the creation of innovative solutions for agricultural challenges, such as pest control and crop protection.
Used in Research and Development:
4-CYANO-4-(3-METHYLPHENYL)CYCLOHEXANONE is utilized in research and development for the synthesis of new compounds with potential biological activity. Its presence in the lab allows scientists to explore its properties and reactions, potentially leading to groundbreaking discoveries in the fields of chemistry and biology.
Check Digit Verification of cas no
The CAS Registry Mumber 73312-15-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,3,1 and 2 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 73312-15:
(7*7)+(6*3)+(5*3)+(4*1)+(3*2)+(2*1)+(1*5)=99
99 % 10 = 9
So 73312-15-9 is a valid CAS Registry Number.
73312-15-9Relevant articles and documents
PHARMACEUTICAL COMPOUNDS
-
Paragraph 00647; 0650; 0867, (2018/04/26)
This invention relates to compounds that are agonists of the muscarinic M1 receptor or M1 and M4 receptors and which are useful in the treatment of muscarinic M1 or M1/M4 receptor mediated